Plain-English translation of NCT06701513 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Psoriasis research guide →This is a real-world study that tracks how well works for adults with moderate-to-severe plaque psoriasis. Rather than testing the medication in a controlled lab setting, researchers will follow people like you who have already decided to start this treatment, watching how your skin improves over time. The goal is to understand how effective this medication is when used by real patients in France.
While the medication has been tested in clinical trials, researchers want to see how well it actually works for patients in their everyday lives — outside of a strict study environment. This real-world information helps doctors and patients understand what to expect and makes sure the medication works as well as hoped for people living with moderate-to-severe plaque psoriasis.
You likely qualify if…
You likely don't qualify if…
You will be followed over time as you take the medication you've already decided to start. Researchers will check in with you periodically to see how your psoriasis is responding, likely through clinic visits or surveys about your skin and overall health. This is a long-term study, so you'll be tracked to gather real-world information about how well the treatment works for you over months or longer.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France